Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

Roche - Transforming the journey for HER2+ breast cancer patients

Value of subcutaneous treatment options for the healthcare system: Introducing flexible care an opportunity to bring treatment closer to patients


02 Dec 2022


Roche - Transforming the journey for HER2+ breast cancer patients


Tumour Site

Breast Cancer


Christian Jackisch


C. Jackisch

Author affiliations

  • Obsterics And Gynecology / Breast And Gynecologic Cancer Center, Sana Klinikum Offenbach GmbH, 63069 - Offenbach am Main/DE


Login to access the resources on OncologyPRO.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.